Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sex hormone-binding globulin (SHBG) is a glycoprotein primarily produced in the liver that binds to sex hormones, such as testosterone and estradiol, and regulates their bioavailability in the bloodstream. SHBG modulates the distribution of these hormones between free and bound states, influencing their access to target tissues. Its levels are affected by hormonal and metabolic factors, and its measurement is clinically relevant for evaluating disorders related to androgen and estrogen activity.
SHBG binds to sex hormones, modulating their bioavailability and access to target tissues.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sex Hormone-Binding Globulin (SHBG).